| Thomas Meyer, MD | |
|
2410 Atherholt Rd, Lynchburg, VA 24501-2148 | |
| (434) 200-5252 | |
| (434) 200-2862 |
| Full Name | Thomas Meyer |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 27 Years |
| Location | 2410 Atherholt Rd, Lynchburg, Virginia |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518941681 | NPI | - | NPPES |
| 010312957 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 0101238337 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centra Health - Lynchburg Gen Hospital | Lynchburg, VA | Hospital |
| Centra Bedford Memorial Hospital | Bedford, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centra Medical Group Llc | 4789606088 | 603 |
| Centra Health, Inc | 6002719713 | 21 |
News Archive
In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.
Adults treated with empagliflozin during hospitalization for acute heart failure experienced a clinical benefit such as increased survival, lower risk of heart failure hospital readmission and an overall improvement in their quality of life, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.
Researchers at Indiana University School of Medicine have discovered new information about how a dangerous parasite takes control of a patient's cells as it spreads throughout their body, an important finding that could help in the development of new drugs to treat this infection.
University of Iowa researchers have succeeded in wiping out established biofilms of Staphylococcus aureus (staph) by hijacking one of the bacteria's own regulatory systems.
Fraser Communications, which has designed award-winning campaigns the past six years for First 5 California, won another 3-year contract with the government organization to promote child brain development, early literacy, healthy nutrition, and other critical information for parents of young children.
› Verified 9 days ago
| Entity Name | Centra Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649228966 PECOS PAC ID: 4789606088 Enrollment ID: O20051230000147 |
News Archive
In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.
Adults treated with empagliflozin during hospitalization for acute heart failure experienced a clinical benefit such as increased survival, lower risk of heart failure hospital readmission and an overall improvement in their quality of life, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.
Researchers at Indiana University School of Medicine have discovered new information about how a dangerous parasite takes control of a patient's cells as it spreads throughout their body, an important finding that could help in the development of new drugs to treat this infection.
University of Iowa researchers have succeeded in wiping out established biofilms of Staphylococcus aureus (staph) by hijacking one of the bacteria's own regulatory systems.
Fraser Communications, which has designed award-winning campaigns the past six years for First 5 California, won another 3-year contract with the government organization to promote child brain development, early literacy, healthy nutrition, and other critical information for parents of young children.
› Verified 9 days ago
| Entity Name | Centra Health, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770693939 PECOS PAC ID: 6002719713 Enrollment ID: O20191218000107 |
News Archive
In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.
Adults treated with empagliflozin during hospitalization for acute heart failure experienced a clinical benefit such as increased survival, lower risk of heart failure hospital readmission and an overall improvement in their quality of life, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.
Researchers at Indiana University School of Medicine have discovered new information about how a dangerous parasite takes control of a patient's cells as it spreads throughout their body, an important finding that could help in the development of new drugs to treat this infection.
University of Iowa researchers have succeeded in wiping out established biofilms of Staphylococcus aureus (staph) by hijacking one of the bacteria's own regulatory systems.
Fraser Communications, which has designed award-winning campaigns the past six years for First 5 California, won another 3-year contract with the government organization to promote child brain development, early literacy, healthy nutrition, and other critical information for parents of young children.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Meyer, MD 2410 Atherholt Rd, Lynchburg, VA 24501-2148 Ph: (434) 200-5252 | Thomas Meyer, MD 2410 Atherholt Rd, Lynchburg, VA 24501-2148 Ph: (434) 200-5252 |
News Archive
In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.
Adults treated with empagliflozin during hospitalization for acute heart failure experienced a clinical benefit such as increased survival, lower risk of heart failure hospital readmission and an overall improvement in their quality of life, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.
Researchers at Indiana University School of Medicine have discovered new information about how a dangerous parasite takes control of a patient's cells as it spreads throughout their body, an important finding that could help in the development of new drugs to treat this infection.
University of Iowa researchers have succeeded in wiping out established biofilms of Staphylococcus aureus (staph) by hijacking one of the bacteria's own regulatory systems.
Fraser Communications, which has designed award-winning campaigns the past six years for First 5 California, won another 3-year contract with the government organization to promote child brain development, early literacy, healthy nutrition, and other critical information for parents of young children.
› Verified 9 days ago
Varsha Reddy Pothula Venkata, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 103 Clifton St, Lynchburg, VA 24501 Phone: 434-455-7100 Fax: 434-947-5909 | |
Dr. James D Cure, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1901 Thomson Dr, Lynchburg, VA 24501 Phone: 434-947-3908 Fax: 434-947-5948 | |
Edward Vincent Bonyak, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 2410 Atherholt Rd, Lynchburg, VA 24501 Phone: 434-200-5252 Fax: 434-200-5252 | |
Sally- Ann Tracy Mcintosh, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2215 Landover Pl, Lynchburg, VA 24501 Phone: 434-947-3944 Fax: 866-617-8273 | |
Dr. John Newton Clore, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 125 Nationwide Dr, Internal Medicine, Lynchburg, VA 24502 Phone: 434-200-3908 | |
Dr. Evan D. Ownby, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 2410 Atherholt Rd, Lynchburg, VA 24501 Phone: 434-200-2712 Fax: 434-200-2851 | |
Dr. Samuel Omotoye, M.D., FRCPC Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2410 Atherholt Rd, Lynchburg, VA 24501 Phone: 434-200-2712 Fax: 434-200-2851 |